Levitt B, Cagin N A, Somberg J C, Kleid J J
Cardiology. 1976;61(1):50-60. doi: 10.1159/000169747.
The pharmacokinetics of ouabain associated with toxicity were studied in the cat and the guinea pig both in vivo and in vitro using ouabain-H3. After spinal cord transection a higher dose of ouabain was required to reach the lethal endpoint. This intervention also increased the myocardial and serum levels associated with toxicity were studied in the cat and the guinea pig both in vivo and in vitro using ouabain-H3. After spinal cord transection a higher dose of ouabain was required to reach the lethal endpoint. This intervention also increased the myocardial and serum levels associated with death. These findings were corroborated in experiments using digitoxin H3. In vitro, substantially higher ouabain tissue contents were associated with a lethal event. In addition, in cats and guinea pigs, the lethal myocardial ouabain content did not change when the infusion rate of ouabain was varied in vivo or the perfusate ouabain concentration was changed in vitro. In vivo, propranolol increases the myocardial ouabain content associated with death to in vitro levels. In vitro, the drugs prolongs the time to death by retarding the myocardial uptake of ouabain. These data suggest that the toxic effects of ouabain in the whole animal are largely neural and in the isolated heart, substantially myocardial.
使用哇巴因 - H3在猫和豚鼠体内及体外研究了与毒性相关的哇巴因药代动力学。脊髓横断后,需要更高剂量的哇巴因才能达到致死终点。这种干预还增加了与死亡相关的心肌和血清水平。在使用洋地黄毒苷H3的实验中证实了这些发现。在体外,与致死事件相关的哇巴因组织含量显著更高。此外,在猫和豚鼠中,当体内哇巴因输注速率改变或体外灌注液中哇巴因浓度改变时,致死性心肌哇巴因含量不变。在体内,普萘洛尔可使与死亡相关的心肌哇巴因含量增加至体外水平。在体外,该药物通过延迟心肌对哇巴因的摄取来延长死亡时间。这些数据表明,哇巴因在整个动物体内的毒性作用主要是神经性的,而在离体心脏中,主要是心肌性的。